Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer
American Society of Clinical Oncology Educational Book · 2026-06 · 46 (3)
DOI: 10.1200/edbk-26-520488 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2026-06. Verfasst von Eitan Amir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Receptors, Progesterone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Treating patients with early-stage hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer is increasingly complex, driven by a growing array of therapeutic options, heterogeneous clinical benefit across patient subgroups, and the risk of treatment-related and financial toxicity. Major advances in tumor biology–guided care have improved risk stratification and helped identify patients most likely to benefit from chemotherapy, especially with the use of genomic assays. In this article, we examine key challenges and ongoing controversies in managing this breast cancer subtype, including the use of genomic assays in premenopausal women with node-positive disease, tailoring treatment in locally advanced tumors with favorable biology, and the current and emerging roles of circulating tumor DNA as a prognostic and predictive biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Princess Margaret Cancer Centre, Toronto, ON, Canada.
- Winship Cancer Institute at Emory University, Atlanta, GA.
- University of Michigan, Ann Arbor, MI.
Zitieren
APA
Amir, E., Kristoff, T., Blaha, C., Bender, U., Kalinsky, K., & Cobain, E. (2026). Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer. American Society of Clinical Oncology Educational Book, 46(3). https://doi.org/10.1200/edbk-26-520488
Vancouver
Amir E, Kristoff T, Blaha C, Bender U, Kalinsky K, Cobain E. Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer. American Society of Clinical Oncology Educational Book. 2026;46(3). doi:10.1200/edbk-26-520488
BibTeX
@article{Amir2026,
author = {Amir, Eitan and Kristoff, Tyler and Blaha, Catherine and Bender, Uri and Kalinsky, Kevin and Cobain, Erin},
title = {Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer},
journal = {American Society of Clinical Oncology Educational Book},
year = {2026},
volume = {46},
number = {3},
doi = {10.1200/edbk-26-520488}
}
EUVIMED